Senior Manager, Medical Marketing

USA (Remote)

$170K/yr – $198K/yrSenior Level8+ years expFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the medical marketing and KOL program strategy for a psychiatry-focused biotech, driving cross-team alignment on launch-ready scientific engagement and evidence generation.

  • KOL & Advisory Board: Identify, segment, engage, and continuously nurture key opinion leaders; oversee boards and congress activities to shape scientific messaging.
  • Congress & Communications: Lead sponsorships, symposia, and publications; ensure materials and stakeholder outreach reinforce credible, compliant scientific exchange.
  • Cross-Functional Orchestration: Align Medical Affairs, Clinical Development, Commercial, and Regulatory activities with brand goals; manage external agencies and synthesize market insights to steer strategy.

Job Description

Responsibilities

  • Develop and execute medical marketing initiatives that support the scientific positioning and successful commercialization of DT120
  • Lead KOL engagement strategy, including identification, segmentation, relationship development, and ongoing engagement planning
  • Manage advisory board planning and execution, including objectives, attendee selection, content development, logistics, and insight capture
  • Support medical congress strategy and execution, including sponsorships, exhibits, symposia, scientific communications, and stakeholder engagement activities
  • Partner with Medical Affairs, Clinical Development, Commercial, and Regulatory teams to align scientific engagement activities with broader organizational objectives
  • Direct external agency partners and vendors supporting congresses, advisory boards, speaker programs, and scientific communications initiatives
  • Gather and synthesize insights from KOL interactions, advisory boards, congresses, and market intelligence to inform brand and evidence-generation strategies
  • Support development of scientific communication materials and engagement initiatives that strengthen awareness, credibility, and launch readiness
Definium Therapeutics logo

Definium Therapeutics

Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. We develop science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives. From day one, we have been powered by a radical idea: treatments for anxiety and depression should bring real relief. Together we’re moving psychiatry forward— beyond better, into a boundless future.Definium Therapeutics trades on the NASDAQ under the symbol DFTX.

Founded in 2019
New York, New York, USA
103 employees

Marketing Team

Median Career Experience
16.5 years
Median Tenure
0.8 years